Back to search

United Kingdom· GB-APID-23163711000001109

Stribild 150mg/150mg/200mg/245mg tablets

A emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat product containing elvitegravir + cobicistat + emtricitabine + tenofovir disoproxil, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR09

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedStribild 150mg/150mg/200mg/245mg tabl…ATCJ05AR09REGISTER NO.GB-APID-2316371100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR09 (emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat · ATC J05AR09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil
Manufacturer
Gilead Sciences Ltd
Country
United Kingdom (GB)
ATC code
J05AR09
ATC class
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    05391507145222
  • gtin
    05391507145239

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Stribild
  • Liechtenstein · Stribild
  • Norway · Stribild

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5616280-e36e-485e-89f1-a4dbf4c09a42
GET /v1/drugs/c5616280-e36e-485e-89f1-a4dbf4c09a42?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "23163711000001109",
  "desc": "Stribild 150mg/150mg/200mg/245mg tablets (Gilead Sciences Ltd)",
  "form": "Oral tablet",
  "vpid": "22088011000001103",
  "source": "dmd",
  "vtm_id": "23167611000001108",
  "strength": "150 mg",
  "substance": "Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil",
  "ingredient": "Elvitegravir",
  "supplier_code": "2572301000001107"
}

See everything about emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.